BIO-Europe Spring® 2016: How to get Takeda Ventures to notice your startup

May 10, 2016
Dr. Ilan Zipkin, senior investment director at Takeda Ventures, talks with Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, about what the venture capital firm is looking for in new investments. During the BIO-Europe Spring partnering meeting in Stockholm, Sweden they discuss the "grey areas" where Takeda is interested in growing business and which areas it avoids, as well as what package entrepreneurs need to bring to the table in order to get Takeda Ventures' attention.
Previous Video
BIO-Europe Spring® 2016: Selexis CEO talks licensing, academic partnerships and biosimilars
BIO-Europe Spring® 2016: Selexis CEO talks licensing, academic partnerships and biosimilars

Dr. Igor Fisch, CEO of Selexis SA, a drug discovery and cell-line development services company, speaks to M...

Next Video
BIO-Europe Spring® 2016: PledPharma seeks partner for lead therapy
BIO-Europe Spring® 2016: PledPharma seeks partner for lead therapy

Jacques Näsström, CEO of Pled Pharma, chats with Sten Stovall, senior editor at Pharma Intelligence, about ...